Financial

Boston Scientific Announces Results For Second Quarter 2019

MARLBOROUGH, Mass., July 24, 2019 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated sales of $2.631 billion during the second quarter of 2019. This represents growth of 5.6 percent on a reported basis, 8.0 percent on an operational1 basis and 6.3 percent on an organic2 basis, all compared to the prior year period. The company reported […]

Ablacon Announces Closing of a $10 Million Venture Debt Facility and $2 Million Equity Investment from Western Technology Investment; Josef Koblish and Melissa Kong to Join the Company

MENLO PARK, Calif., July 23, 2019 /PRNewswire/ — Ablacon Inc. announced today that it has entered into a $10 millionventure debt facility with Western Technology Investment (WTI). The debt is accompanied by a $2 million equity investment in the Company. This financing will help fund Ablacon’s first multicenter randomized clinical trial for Ablamap, an advanced mapping […]

Edwards Lifesciences Reports Second Quarter Results

IRVINE, Calif., July 23, 2019 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended June 30, 2019. Second Quarter and Recent Highlights Sales grew 15% to $1.1 billion; underlying1 sales grew 14% TAVR sales grew 16%; underlying […]

Olivier Chaudoir Joins BioSig as Director of Marketing

Westport, CT, July 18, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing technology platform designed to address an unmet need for the electrophysiology (EP) marketplace, today announced that Mr. Olivier Chaudoir joined the Company as Director of Marketing. Mr. Chaudoir brings to […]

Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule, Resolving Last Remaining Outstanding Nasdaq Deficiency

VANCOUVER, July 17, 2019 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN) (TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, announced today that it has received written notification (the “Nasdaq […]

Leviticus Cardio Appoints Prof. Mandeep R. Mehra to Its Scientific Advisory Board

PETAH-TIKVA, Israel, July 16, 2019 /PRNewswire/ — Leviticus Cardio today announced the appointment of Prof. Mandeep R. Mehra to its Scientific Advisory Board. “We are very excited that Prof. Mehra has joined our Scientific Advisory Board. He is recognized as one of the world’s leading cardiologists in advanced heart failure and cardiac transplantation, and he will provide immediate […]

Filterlex Medical Raised $3M in Series A Financing

Filterlex won the best innovation award at the EuroPCR 2019 conference in Paris and was awarded $200,000 prize by the Jon DeHaan Foundation YOKNEAM, Israel, July 15, 2019 /PRNewswire/ — Filterlex Medical is a medical device start-up company, developing an innovative embolic protection device (CAPTIS) for reducing the risk of stroke and other complications during catheter-based structural heart procedures. […]